Dr. Ouellette is the Scientific Director of the Institute of Infectious Disease and Immunity of the
Canadian Institutes of Health Research (CIHR) since January 1st, 2010. In this capacity, he has led
the conception and implementation of several research initiatives in the areas of organ
transplantation, inflammation, microbiome, vaccines and antibiotic resistance. Dr. Ouellette also
oversees the development and outcomes of the HIV/AIDS and Hepatitis C Research Initiatives.
He provided scientific leadership for pandemic influenza, Ebola and now Zika and has worked on
funding opportunities to better respond to these emerging threats.
Dr. Ouellette obtained his Bachelor of Science (Honours) in Biochemistry at Ottawa University
and received his PhD at Laval University on antibiotic resistance in bacteria. His postdoctoral
studies were done under the mentorship of Pr. Piet Borst of the Netherlands Cancer Institute in
Amsterdam, where he further developed his expertise in antimicrobial resistance studying protozoan
In 1990 he joined the Centre de Recherche en Infectiologie, of Laval University as an Assistant
professor and is now full professor. Dr. Ouellette’s research is focused on antimicrobial
resistance where he has made seminal discoveries on resistance mechanism in protozoan
parasites. More recently he has implemented proteomic and DNA microarray strategies to study
antimicrobial resistance in the parasite Leishmania and the bacteria Streptococcus pneumoniae.
Dr. Ouellette has received numerous awards for his work including a New Investigator Award in
Molecular Parasitology from the Burroughs Wellcome Fund, a MRC Scientist Award, a Scholar
Award in Molecular Parasitology of the Burroughs Wellcome Fund, and a Tier 1 Canada Research
Chair in Antimicrobial Resistance. He is a Fellow of the Royal Society of Canada and of the
Canadian Academy of Health Sciences. He has served on numerous panels of national and
international granting agencies and is a strong supporter of scientific exchanges with developing countries.